Pharma and Biotech Financial Trends – A Frenzy of Activity (Young & Partners article written for the Pharma Exec Dec 2014 Issue)
Young & Partners dissects the drivers behind the frenzy of biopharma M&A and financial activity
The Normal and Abnormal in Equity (Young & Partners Article in ICIS Chemical Business October 6-12, 2014 issue)
The disconnect between high valuations of public stocks and low demand for chemical IPOs
Chemical M&A solid in first half, expected to rise (Young & Partners interview in Chemical Week -September 22 – 29, 2014 issue)
Peter Young dissects the strong M&A activity and what is happening in the financing markets
Pharma M&A Diverse and Accelerating (Young & Partners article in Pharma Exec on Sept. 18, 2014)
Young & Partners explains what is driving the current frenzy of M&A activity
M&A on the rise (Young & Partners Article in ICIS Chemical Business Sept. 1, 2014 issue)
Young & Partners explains what is driving the rising M&A market and what it means
Global chemical M&A to pick up in second half 2014 – (ICIS Chemical Business August 4, 2014 issue)
Peter Young of Young & Partners is interviewed by the ICIS Chemical Business Global Editor
Chemical M&A – The Devil is in the Details (Y&P Article – ICIS Chemical Business May 26 – June 1, 2014 issue)
Young & Partners authors article explaining the unusual underlying factors driving the M&A market
Chemicals M&A Steady in First Quarter – Chemical Week (May 19-26, 2014)
Peter Young of Young & Partners interviewed about the factors behind the strong M&A market
Chemical M&A strength in 2013 expected to continue (Chemical Week March 3, 2014 issue)
Chemical Week interviews Peter Young of Young & Partners about M&A in 2013 and 2014
Young & Partner Article – Positive M&A to Continue in 2014 (ICIS Chemical Business Feb 24, 2014 issue)
Young & Partners' view of 2013 (M&A, financial and business) and the outlook for 2014